{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:00:18Z","timestamp":1792159218803,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI157046"],"award-info":[{"award-number":["AI157046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI147325"],"award-info":[{"award-number":["AI147325"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69351-x","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:43:26Z","timestamp":1770705806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rational design and in vivo validation of capsid inhibitors for enterovirus D68"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-1934","authenticated-orcid":false,"given":"Kan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-9792","authenticated-orcid":false,"given":"Thomas","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhou","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot A.","family":"Demssie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-1026","authenticated-orcid":false,"given":"Richard J.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-5888","authenticated-orcid":false,"given":"Kenneth L.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4621","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"69351_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/v11060490","volume":"11","author":"J Sun","year":"2019","unstructured":"Sun, J., Hu, X. Y. & Yu, X. F. Current Understanding of Human Enterovirus D68. Viruses 11, 490 (2019).","journal-title":"Viruses"},{"key":"69351_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","volume":"16","author":"J Baggen","year":"2018","unstructured":"Baggen, J., Thibaut, H. J., Strating, J. & van Kuppeveld, F. J. M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 16, 368\u2013381 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"69351_CR3","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3389\/fmicb.2018.02677","volume":"9","author":"H Cassidy","year":"2018","unstructured":"Cassidy, H., Poelman, R., Knoester, M., Van Leer-Buter, C. C. & Niesters, H. G. M. Enterovirus D68 - The New Polio? Front. Microbiol. 9, 2677 (2018).","journal-title":"Front. Microbiol."},{"key":"69351_CR4","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1099\/vir.0.79925-0","volume":"85","author":"MS Oberste","year":"2004","unstructured":"Oberste, M. S. et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 85, 2577\u20132584 (2004).","journal-title":"J. Gen. Virol."},{"key":"69351_CR5","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S1473-3099(15)00543-5","volume":"16","author":"CC Holm-Hansen","year":"2016","unstructured":"Holm-Hansen, C. C., Midgley, S. E. & Fischer, T. K. Global emergence of enterovirus D68: a systematic review. Lancet Infect. Dis. 16, e64\u2013e75 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"69351_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2213-2600(15)00335-5","volume":"3","author":"CM Midgley","year":"2015","unstructured":"Midgley, C. M. et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir. Med. 3, 879\u2013887 (2015).","journal-title":"Lancet Respir. Med."},{"key":"69351_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ana.24730","volume":"80","author":"K Messacar","year":"2016","unstructured":"Messacar, K. et al. Acute flaccid myelitis: A clinical review of US cases 2012-2015. Ann. Neurol. 80, 326\u2013338 (2016).","journal-title":"Ann. Neurol."},{"key":"69351_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2018.23.3.17-00310","volume":"23","author":"A Dyda","year":"2018","unstructured":"Dyda, A., Stelzer-Braid, S., Adam, D., Chughtai, A. A. & MacIntyre, C. R. The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) \u2013 what is the evidence for causation? Eur. Surveill. 23, 17\u201300310 (2018).","journal-title":"Eur. Surveill."},{"key":"69351_CR9","doi-asserted-by":"publisher","first-page":"e00521","DOI":"10.1128\/mBio.00521-19","volume":"10","author":"DM Morens","year":"2019","unstructured":"Morens, D. M., Folkers, G. K. & Fauci, A. S. Acute Flaccid Myelitis: Something Old and Something New. mBio 10, e00521\u201319 (2019).","journal-title":"mBio"},{"key":"69351_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01954-18","volume":"9","author":"DM Brown","year":"2018","unstructured":"Brown, D. M. et al. Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells. mBio 9, e01954-18 (2018).","journal-title":"mBio"},{"key":"69351_CR11","doi-asserted-by":"publisher","first-page":"e1006199","DOI":"10.1371\/journal.ppat.1006199","volume":"13","author":"AM Hixon","year":"2017","unstructured":"Hixon, A. M. et al. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog. 13, e1006199 (2017).","journal-title":"PLoS Pathog."},{"key":"69351_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1021\/acsinfecdis.0c00120","volume":"6","author":"Y Hu","year":"2020","unstructured":"Hu, Y., Musharrafieh, R., Zheng, M. & Wang, J. Enterovirus D68 Antivirals: Past, Present, and Future. ACS Infect. Dis. 6, 1572\u20131586 (2020).","journal-title":"ACS Infect. Dis."},{"key":"69351_CR13","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1128\/AAC.02182-15","volume":"60","author":"R Ulferts","year":"2016","unstructured":"Ulferts, R. et al. Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C. Antimicrob. Agents Chemother. 60, 2627\u20132638 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69351_CR14","doi-asserted-by":"publisher","first-page":"e3000904","DOI":"10.1371\/journal.pbio.3000904","volume":"18","author":"L Bauer","year":"2020","unstructured":"Bauer, L. et al. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C. PLoS Biol. 18, e3000904 (2020).","journal-title":"PLoS Biol."},{"key":"69351_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1021\/acsinfecdis.9b00179","volume":"5","author":"L Bauer","year":"2019","unstructured":"Bauer, L. et al. Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner. ACS Infect. Dis. 5, 1609\u20131623 (2019).","journal-title":"ACS Infect. Dis."},{"key":"69351_CR16","doi-asserted-by":"publisher","first-page":"103981","DOI":"10.1016\/j.bioorg.2020.103981","volume":"101","author":"R Musharrafieh","year":"2020","unstructured":"Musharrafieh, R., Kitamura, N., Hu, Y. & Wang, J. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold. Bioorg. Chem. 101, 103981 (2020).","journal-title":"Bioorg. Chem."},{"key":"69351_CR17","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1021\/acs.jmedchem.9b00115","volume":"62","author":"R Musharrafieh","year":"2019","unstructured":"Musharrafieh, R. et al. Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). J. Med. Chem. 62, 4074\u20134090 (2019).","journal-title":"J. Med. Chem."},{"key":"69351_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1128\/AAC.02646-15","volume":"60","author":"J Zuo","year":"2015","unstructured":"Zuo, J. et al. Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses. Antimicrob. Agents Chemother. 60, 1615\u20131626 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69351_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.virol.2018.10.014","volume":"526","author":"BL Hurst","year":"2019","unstructured":"Hurst, B. L., Evans, W. J., Smee, D. F., Van Wettere, A. J. & Tarbet, E. B. Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice. Virology 526, 146\u2013154 (2019).","journal-title":"Virology"},{"key":"69351_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/infdis\/jix468","volume":"216","author":"AM Hixon","year":"2017","unstructured":"Hixon, A. M., Clarke, P. & Tyler, K. L. Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. J. Infect. Dis. 216, 1245\u20131253 (2017).","journal-title":"J. Infect. Dis."},{"key":"69351_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00156-23","volume":"97","author":"J Frost","year":"2023","unstructured":"Frost, J. et al. Telaprevir Treatment Reduces Paralysis in a Mouse Model of Enterovirus D68 Acute Flaccid Myelitis. J. Virol. 97, e0015623 (2023).","journal-title":"J. Virol."},{"key":"69351_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61083-8","volume":"16","author":"K Li","year":"2025","unstructured":"Li, K. et al. A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Nat. Commun. 16, 5987 (2025).","journal-title":"Nat. Commun."},{"key":"69351_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105654","volume":"216","author":"TR Lane","year":"2023","unstructured":"Lane, T. R. et al. Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5. Antivir. Res. 216, 105654 (2023).","journal-title":"Antivir. Res."},{"key":"69351_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.1261962","volume":"347","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347, 71\u201374 (2015).","journal-title":"Science"},{"key":"69351_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","volume":"2","author":"K Senior","year":"2002","unstructured":"Senior, K. FDA panel rejects common cold treatment. Lancet Infect. Dis. 2, 264 (2002).","journal-title":"Lancet Infect. Dis."},{"key":"69351_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ejmech.2019.06.008","volume":"178","author":"A Egorova","year":"2019","unstructured":"Egorova, A., Ekins, S., Schmidtke, M. & Makarov, V. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses. Eur. J. Med. Chem. 178, 606\u2013622 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"69351_CR27","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1128\/AAC.01375-15","volume":"59","author":"L Sun","year":"2015","unstructured":"Sun, L. et al. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob. Agents Chemother. 59, 7782\u20137785 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69351_CR28","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1128\/AAC.00766-15","volume":"59","author":"E Rhoden","year":"2015","unstructured":"Rhoden, E., Zhang, M., Nix, W. A. & Oberste, M. S. In Vitro Efficacy of Antiviral Compounds against Enterovirus D68. Antimicrob. Agents Chemother. 59, 7779\u20137781 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69351_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2016.04.003","volume":"131","author":"DF Smee","year":"2016","unstructured":"Smee, D. F., Evans, W. J., Nicolaou, K. C., Tarbet, E. B. & Day, C. W. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antivir. Res 131, 61\u201365 (2016).","journal-title":"Antivir. Res"},{"key":"69351_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1021\/acsinfecdis.9b00284","volume":"5","author":"C Ma","year":"2019","unstructured":"Ma, C., Hu, Y., Zhang, J., Musharrafieh, R. & Wang, J. A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68. ACS Infect. Dis. 5, 1952\u20131962 (2019).","journal-title":"ACS Infect. Dis."},{"key":"69351_CR31","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1021\/acs.jmedchem.1c00758","volume":"64","author":"Y Hu","year":"2021","unstructured":"Hu, Y., Kitamura, N., Musharrafieh, R. & Wang, J. Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein. J. Med. Chem. 64, 8755\u20138774 (2021).","journal-title":"J. Med. Chem."},{"key":"69351_CR32","doi-asserted-by":"publisher","first-page":"e02221","DOI":"10.1128\/JVI.02221-18","volume":"93","author":"R Musharrafieh","year":"2019","unstructured":"Musharrafieh, R. et al. Validating Enterovirus D68-2A(pro) as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2A(pro) Inhibitor. J. Virol. 93, e02221\u201302218 (2019).","journal-title":"J. Virol."},{"key":"69351_CR33","doi-asserted-by":"publisher","first-page":"14544","DOI":"10.1021\/acs.jmedchem.3c00995","volume":"66","author":"B Tan","year":"2023","unstructured":"Tan, B. et al. Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors. J. Med. Chem. 66, 14544\u201314563 (2023).","journal-title":"J. Med. Chem."},{"key":"69351_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets. Genomics, Proteom. Bioinforma. 20, 587\u2013596 (2022).","journal-title":"Genomics, Proteom. Bioinforma."},{"key":"69351_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav, B., Wennerberg, K., Aittokallio, T. & Tang, J. Searching for Drug Synergy in Complex Dose\u2013Response Landscapes Using an Interaction Potency Model. Comput Struct. Biotechnol. J. 13, 504\u2013513 (2015).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"69351_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00227-22","volume":"66","author":"MichaelJ Rudy","year":"2022","unstructured":"Rudy, M. ichaelJ., Penny Clarke, J. F. & Tyler, K. ennethL. Neutralizing antibody given after paralysis onset reduces the severity of paralysis compared to non-specific antibody treated controls in a mouse model of EV-D68 associated acute flaccid myelitis. Antimicrob. Agents Chemother. 66, e0022722 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69351_CR37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto, G., del Peso, A. & Zurita, J. L. Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat. Protoc. 3, 1125\u20131131 (2008).","journal-title":"Nat. Protoc."},{"key":"69351_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115667","volume":"259","author":"B Tan","year":"2023","unstructured":"Tan, B. et al. Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors. Eur. J. Med. Chem. 259, 115667 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"69351_CR39","doi-asserted-by":"publisher","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzman","year":"2014","unstructured":"Guzman, C., Bagga, M., Kaur, A., Westermarck, J. & Abankwa, D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS One 9, e92444 (2014).","journal-title":"PLoS One"},{"key":"69351_CR40","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1021\/acsinfecdis.0c00383","volume":"6","author":"C Ma","year":"2020","unstructured":"Ma, C., Hu, Y., Zhang, J. & Wang, J. Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68. ACS Infect. Dis. 6, 2260\u20132270 (2020).","journal-title":"ACS Infect. Dis."},{"key":"69351_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2018.03.002","volume":"153","author":"R Musharrafieh","year":"2018","unstructured":"Musharrafieh, R., Ma, C. & Wang, J. Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers. Antivir. Res. 153, 10\u201322 (2018).","journal-title":"Antivir. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69351-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:14:40Z","timestamp":1774984480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69351"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69351-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rutgers, the State University of New Jersey, has applied for a provisional patent that covers the VP1 inhibitors reported in this manuscript and related compounds. The inventors include K.L. and J.W. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3052"}}